References
- Groves FD, Linet MS, Travis LB, Devesa SS. Cancer surveillance series: non-Hodgkin's lymphoma incidence by histologic subtypes in the United States from 1978 through 1995. J Natl Cancer Inst 2000; 92: 1240–1251.
- Parkin DM, Pisani P, Ferlay J. Global cancer statistics. CA CancerJ Clin 1999; 49: 33–64.
- Devesa SS, Fears T. Non-Hodgkin's lymphoma time trends: United States and international data. Cancer Res 1992; 52 (Suppl.): S5432—S5440.
- Zucca E, Roggero E, Bertoni F, Cavalli F. Primary extranodal non-Hodgkin's lymphomas. Part 1: gastrointestinal, cutaneous and genitourinary lymphomas. Ann Oncol 1997; 8: 727–737.
- Zucca E, Roggero E, Bertoni F, Cavalli F. Primary extranodal non-Hodgkin's lymphomas. Part 2: head and neck, central nervous system and other less common sites. Ann Oncol 1999: 8: 1023–1033.
- Weisenburger DD. Epidemiology of non-Hodgkin's lymphoma: recent findings regarding an emerging epidemic. Ann Oncol 1994; 5 (Suppl. 1): S19—S24.
- Public Authority for Civil Information (PAC). Directory of civilinformation; regulations and labor force. Kuwait city: PACT, 2003.
- Al-Shemmari SH, Sajnani KP, Ameen RM, Ragheb AM. Primarygastrointestinal non-Hodgkin's lymphoma: treatment outcome. Clin Lymphoma 2003; 4 (2): 99–103.
- WHO classification of Tumors: Pathology and genetics of tumors: haematopoietic and lymphoid tissues. Lyon: IARC Press; 2001.
- Carbone PP, Kaplan HS, Musshoff K et al. Report of the Committee on Hodgkin's disease staging classification. Cancer Res 1971; 31: 1860–1861.
- The Non-Hodgkin's Lymphoma Classification Project. A clinical evaluation of the International Lymphoma Study Group classifi-cation of non-Hodgkin's lymphoma. Blood 1997; 89: 3909–3918.
- Rosenberg SA. Validity of the Ann Arbor staging classification for the non-Hodgkin's lymphomas. Cancer Treat Rep 1977; 61: 1023–1027.
- Musshoff K. Classification of the clinical stages of non-Hodgkin'slymphoma. Strahlentherapie 1977; 153: 218–221.
- Freeman C, Berg JW, Cutler Si. Occurrence and prognosis of extranodal lymphomas. Cancer 1972; 29: 252–260.
- Gospodarowicz MK, Sutcliffe SB. The extranodal lymphomas. Semin Radia Oncol 1995; 5: 281–300.
- Paryani S, Hoppe RT, Burke JS et al. Extralymphatic involvement indiffuse non-Hodgkin's lymphoma. J Clin Onco11983; 1: 682–688.
- Rudders RA, Ross ME, DeLellis RA. Primary extranodal lymphoma: response to treatment and factors influencing prog-nosis. Cancer 1978; 42: 406–416.
- d'Amore F, Christensen BE, Brincker H et al. Clinicopathological features and prognostic factors in extranodal non-Hodgkin lymphomas. Danish LYFO Study Group. Eur J Cancer 1991; 27: 1201–1208.
- Economopoulos T, Asprou N, Stathakis N et al. Primary extranodal non- Hodgkin's lymphoma in adults: clinicopathologi-cal and survival characteristics. Leuk Lymphoma 1996; 21: 131–136.
- Zucca E, Roggero E, Bertoni F et al. Primary extranodal non-Hodgkin's lymphomas. Part 1: gastrointestinal, cutaneous and genitourinary lymphomas. Ann Oncol 1997; 8: 727–737.
- Lewin KJ, Ranchod M, Dorfman RF. Lymphomas of the gastrointestinal tract: a study of 117 cases presenting with gastrointestinal disease. Cancer 1978; 42: 693–707.
- Glass AG, Karnell LH, Menck HR. The National Cancer Data Base report on non-Hodgkin's lymphoma. Cancer 1997; 80: 2311–2320.
- Levine P, Hoover RN. The emerging epidemic of non-Hodgkin's lymphoma: current knowledge regarding etiologic factors. Cancer Res 1992; 2 (Suppl.): S5425— S5474.
- Otter R, Gerrits WB, Sandt MM et al. Primary extranodal and nodal non- Hodgkin's lymphoma. A survey of a population-based registry. Eur J Cancer Clin Oncol 1989; 25: 1203–1210.
- Krol ADG, le Cessie S, Snijder S, Kluin-Nelemans JC, Kluin PM, Noordijk EM. Primary extranodal non-Hodgkin's lymphoma (NHL): the impact of alternative definitions tested in the Comprehensive Cancer Centre West population-based NHL registry. Annals of Oncology 2003; 14: 131–139.
- Gronbaek K, Thor Straten P, Ralfkiaer E et al. Somatic Fas mutations in non- Hodgkin's lymphoma: association with extra-nodal disease and autoimmunity. Blood 1998; 92: 3018–3024.
- Rao PH, Houldsworth J, Dyomina K et al. Chromosomal and gene amplification in diffuse large B-cell lymphoma. Blood 1998; 92: 234–240.
- Moller MB, Pedersen NT, Christensen BE. Diffuse large B-cell lymphoma: clinical implications of extranodal versus nodal presentation—a population-based study of 1575 cases. Br J Haematol 2004; 124: 151–159.
- Gospodarowicz MK, Sutcliffe SB, Brown TC et al. Patterns of disease in localized extranodal lymphomas. J Clin Oncol 1987; 5: 875–880.